Around 35 companies have shown interest in the second round of the PLI scheme for specialty steel, with commitment of Rs ...

Given the high cost and complexity of achieving certifications like FDA clearance or CE marking approvals, would it be ...

Donald Trump has hit steel and aluminium with tariffs and the US is eyeing Australia's agriculture and pharmaceutical industries next.

In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...

Welcome to Edition 7.36 of the Rocket Report! Well, after nine months, NASA astronauts Butch Wilmore and Suni Williams are ...

Australia trade war has left consumers wondering what this means for them. At least in the short term, it looks like good ...

It takes courage for a business to pivot – especially a publicly listed one answerable to shareholders – but biotech Clever ...

While AI adoption in GMP settings is still evolving, regulatory agencies emphasize explainability and validation of AI models ...

The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the ways that tariffs disrupt pharma supply ...

Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.